The U.S. Food and Drug Administration today approved the first totally implanted artificial heart for patients with advanced heart failure.

The AbioCor Implantable Replacement Heart, made by Abiomed, Inc. (Danvers, Mass.), is intended for people who are not eligible for a heart transplant and who are unlikely to live more than a month without intervention. In clinical studies, this product was shown to prolong the life and improve the quality of life for critically ill patients.

The AbioCor Replacement Heart is implanted in your body, where it takes the place of your natural heart to keep the blood flowing normally through your body.

Abicor II next generation implantable replacement heart, the AbioCor II, incorporates the best technologies of both the AbioCor and the Penn State Heart. The AbioCor II is smaller, and therefore able to fit significantly more of the adult population, and is being designed with the goal of five-year reliability.

Reference - FDA, AbioMed

Technorati Tags: Abiocor, AbioCor II, Abiomed, Artificial heart, Heart Replacement, Implantable heart

Powered by MightyAdsense

This entry was posted on Tuesday, September 5th, 2006 at 11:53 pm and is filed under Health News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.